UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002021
Receipt number R000002467
Scientific Title A randomised crossover study comparing tafluprost and travoprost in subjects with normal tension glaucoma of pseudophakic eye
Date of disclosure of the study information 2009/06/15
Last modified on 2009/05/31 06:20:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomised crossover study comparing tafluprost and travoprost in subjects with normal tension glaucoma of pseudophakic eye

Acronym

The effect of tafluprost and travoprost in subjects with normal tension glaucoma of pseudophakic eye

Scientific Title

A randomised crossover study comparing tafluprost and travoprost in subjects with normal tension glaucoma of pseudophakic eye

Scientific Title:Acronym

The effect of tafluprost and travoprost in subjects with normal tension glaucoma of pseudophakic eye

Region

Japan


Condition

Condition

Normal tension glaucoma of pseudophakic eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of tafluprost and travoprost on intraocular pressure and safety in subjects with normal tension glaucoma of pseudophakic eye in open-label, randomized crossover test

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Intraocular pressure reduction, % reduction of intraocular pressure

Key secondary outcomes

Safety


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Washout in treated with glaucoma medication for 1 month

Interventions/Control_2

Tafluprost or travoprost monotherapy 12 weeks treatment once a day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1; The patients with normal tension glaucoma of pseudophakic eye
2; Untreated or over 4 weeks washout in treated with glaucoma medications

Key exclusion criteria

1; Patients with exfoliation glaucoma and neovascular glaucoma
2; Patients with diabetic retinopathy
3; Excessive myopia before cataract surgery(>-6D)
4; Patients with advanced visual field loss(>-15dB)
5; Any corneal abnormality or other condition preventing reliable applanation tonometry
6; Presence of any external ocular disease, uveitis or infection of the eye and/or eye lid
7; History of refractive surgery
8; History of laser trabeculoplasty, filtering surgery, trabeculotomy and vitorectomy
9; Pregnant, pregnant suspect, and nursing woman. Woman who is wishing pregnancy or preventing pregnancy
10; The Investigator declare any subject ineligible for any sound medical reasion

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takanori MIzoguchi

Organization

MIzoguchi Eye Clinic

Division name

Ophthalmology

Zip code


Address

6-13 Tawaramachi Sasebo Nagasaki Japan 857-0016

TEL

0956-22-5681

Email



Public contact

Name of contact person

1st name
Middle name
Last name Takanori Mizoguchi

Organization

MIzoguchi Eye Clinic

Division name

Ophthalmology

Zip code


Address

6-13 Tawaramachi Sasebo Nagasaki Japan 857-0016

TEL

0956-22-5681

Homepage URL


Email

t-mizo@siren.ocn.ne.jp


Sponsor or person

Institute

MIzoguchi Eye Clinic

Institute

Department

Personal name



Funding Source

Organization

Non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Non


Other related organizations

Co-sponsor

Non

Name of secondary funder(s)

Non


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2009 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 08 Month 01 Day

Last follow-up date

2009 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 31 Day

Last modified on

2009 Year 05 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002467


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name